Compare Badger Meter Inc (BMI) vs Bristol-Myers Squibb Co (BMY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Badger Meter Inc vs Bristol-Myers Squibb Co — how do they compare? Badger Meter Inc trades at $137.51 (market cap $3.93B), while Bristol-Myers Squibb Co trades at $63.7 (market cap $129.94B). The key difference: Bristol-Myers Squibb Co is far larger — about 33.1× Badger Meter Inc's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMI | BMY | |
|---|---|---|
Market Cap | $3.93B | $129.94B |
Sector | Technology | Health |
52-Week High | $193.09 | $65.89 |
52-Week Low | $113.41 | $42.60 |
Enterprise Value | $3.84B | $163.92B |
Dividend Yield | 1.18% | 3.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Badger Meter Inc
Badger Meter provides industry-leading water management solutions. Its smart measurement hardware and software analytics help water utilities and industrial customers optimize operations and conserve natural resources.
Read more on BMI →About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →
